656 related articles for article (PubMed ID: 16376330)
1. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Folkman J
Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
[TBL] [Abstract][Full Text] [Related]
2. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis inhibitors in cancer therapy.
Dredge K; Dalgleish AG; Marriott JB
Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
[TBL] [Abstract][Full Text] [Related]
5. Endostatin: the logic of antiangiogenic therapy.
Abdollahi A; Hlatky L; Huber PE
Drug Resist Updat; 2005; 8(1-2):59-74. PubMed ID: 15939343
[TBL] [Abstract][Full Text] [Related]
6. Endogenous angiogenesis inhibitors.
Folkman J
APMIS; 2004; 112(7-8):496-507. PubMed ID: 15563312
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and cancer: recent advances.
Cáceres W; González S
P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
9. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
11. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
Crawford Y; Ferrara N
Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis as a therapeutic target.
Ferrara N; Kerbel RS
Nature; 2005 Dec; 438(7070):967-74. PubMed ID: 16355214
[TBL] [Abstract][Full Text] [Related]
13. Antitumor interaction of short course endostatin and ionizing radiation.
Greenberger JS
Cancer J; 2000; 6(5):279-81. PubMed ID: 11079164
[No Abstract] [Full Text] [Related]
14. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
15. Process in the mechanisms of endostatin combined with radiotherapy.
Zhuang HQ; Yuan ZY
Cancer Lett; 2009 Sep; 282(1):9-13. PubMed ID: 19136200
[TBL] [Abstract][Full Text] [Related]
16. Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance.
Cao Y; Zhong W; Sun Y
Semin Cancer Biol; 2009 Oct; 19(5):338-43. PubMed ID: 19481151
[TBL] [Abstract][Full Text] [Related]
17. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
18. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis: an update and potential drug approaches (review).
Abdelrahim M; Konduri S; Basha R; Philip PA; Baker CH
Int J Oncol; 2010 Jan; 36(1):5-18. PubMed ID: 19956828
[TBL] [Abstract][Full Text] [Related]
20. [Cerebral tumors and neoangiogenesis ].
Jouanneau E; Bachelot T
Neurochirurgie; 1999 Nov; 45(4):293-300. PubMed ID: 10599057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
